RPTX – repare therapeutics inc. - common shares (US:NASDAQ)
Stock Stats
News
Repare Shareholders Approve Acquisition by XenoTherapeutics, Inc.
Gilead Sciences to acquire Repare's RP-3467 [Yahoo! Finance]
Repare Therapeutics Announces Acquisition of Pol? ATPase Inhibitor, RP-3467, by Gilead Sciences for Up To $30 Million in Total Consideration
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Repare Therapeutics Inc. (Nasdaq – RPTX), Axalta Coating Systems Ltd. (NYSE – AXTA), Blue Foundry Bancorp (Nasdaq – BLFY), Golden Entertainment, Inc (Nasdaq - GDEN)
Halper Sadeh LLC Encourages RPTX, AXTA, BLFY, GDEN Shareholders to Contact the Firm to Discuss Their Rights
Form 8-K Repare Therapeutics Inc. For: Jan 16
Form DEFA14A Repare Therapeutics Inc.
Form 8-K Repare Therapeutics Inc. For: Dec 23
Form DEFA14A Repare Therapeutics Inc.
Form 8-K Repare Therapeutics Inc. For: Dec 18
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.